Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 17.22 USD -1.94%
Market Cap: 1.2B USD

Intrinsic Value

The intrinsic value of one PHAT stock under the Base Case scenario is hidden USD. Compared to the current market price of 17.22 USD, Phathom Pharmaceuticals Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PHAT Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Phathom Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

PHAT looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if PHAT is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PHAT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PHAT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Phathom Pharmaceuticals Inc.

Explain Valuation
Compare PHAT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PHAT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Phathom Pharmaceuticals Inc

Current Assets 207.8m
Cash & Short-Term Investments 135.2m
Receivables 55.8m
Other Current Assets 16.8m
Non-Current Assets 32.5m
PP&E 3.9m
Other Non-Current Assets 28.7m
Current Liabilities 93.1m
Accounts Payable 1.1m
Accrued Liabilities 67.7m
Other Current Liabilities 24.3m
Non-Current Liabilities 569.7m
Long-Term Debt 556.1m
Other Non-Current Liabilities 13.6m
Efficiency

Free Cash Flow Analysis
Phathom Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Phathom Pharmaceuticals Inc

Revenue
147.2m USD
Cost of Revenue
-18.8m USD
Gross Profit
128.4m USD
Operating Expenses
-341.9m USD
Operating Income
-213.5m USD
Other Expenses
-61.1m USD
Net Income
-274.6m USD
Fundamental Scores

PHAT Profitability Score
Profitability Due Diligence

Phathom Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Exceptional Gross Margin
hidden
Profitability
Score

Phathom Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PHAT Solvency Score
Solvency Due Diligence

Phathom Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

Phathom Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHAT Price Targets Summary
Phathom Pharmaceuticals Inc

Wall Street analysts forecast PHAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHAT is 22.85 USD with a low forecast of 12.12 USD and a high forecast of 30.45 USD.

Lowest
Price Target
12.12 USD
30% Downside
Average
Price Target
22.85 USD
33% Upside
Highest
Price Target
30.45 USD
77% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Phathom Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PHAT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PHAT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PHAT stock?

The intrinsic value of one PHAT stock under the Base Case scenario is hidden USD.

Is PHAT stock undervalued or overvalued?

Compared to the current market price of 17.22 USD, Phathom Pharmaceuticals Inc is hidden .

Back to Top